Asie · Marchés régionaux · The Investor

Samsung Bioepis secures 10-year biosimilar supply deal in Brazil

Publié par The Investor · Corée du Sud il y a 23 h

Samsung Bioepis said Tuesday it has secured a 10-year deal to exclusively supply its rare disease biosimilar SB12 to Brazil's public health system, strengthenin ...

Lire l'article complet sur The Investor Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.theinvestor.co.kr)

Samsung Bioepis secures 10-year biosimilar supply deal in Brazil

À lire aussi

Braze stock surges over 50% after Salesforce announces $5.66 billion acquisition

ดอลลาร์อ่อนค่า สอดคล้องบอนด์ยีลด์อ่อนตัว

US markets set to open lower as AI stocks slide and oil tops $100

Monetary policy could turn accommodative as AI productivity gains take hold: MAS chief economist

Faster delivery, easier credit fuel South-east Asia e-commerce: survey

$800 million asset manager to shift 2 funds out of GIFT on tax issues

Samsung Bioepis secures 10-year biosimilar supply deal in Brazil

Partager

À lire aussi

Braze stock surges over 50% after Salesforce announces $5.66 billion acquisition

ดอลลาร์อ่อนค่า สอดคล้องบอนด์ยีลด์อ่อนตัว

US markets set to open lower as AI stocks slide and oil tops $100

Monetary policy could turn accommodative as AI productivity gains take hold: MAS chief economist

Faster delivery, easier credit fuel South-east Asia e-commerce: survey

$800 million asset manager to shift 2 funds out of GIFT on tax issues